| JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | RVI BIOTECNOLOGÍA | 77,918536 | 24/09/2026 | 21,30% | 28,44% | ** |
| ARTEMIS US SELECT I ACC GBP | RVI USA | 6,814598 | 24/09/2026 | 21,29% | · | ND |
| ARTEMIS US SELECT I INC GBP | RVI USA | 6,006792 | 24/09/2026 | 21,29% | · | ND |
| ARTEMIS US SMALLER COMPANIES I ACC GBP | RVI USA SMALL/MID CAP | 6,071221 | 24/09/2026 | 21,29% | · | ND |
| DWS ESG AKKUMULA ID | RVI GLOBAL | 2.860,180000 | 24/09/2026 | 21,29% | 66,36% | ***** |
| JPMORGAN ETFS(IRL)ICAV-JAPAN RESEARCH ENHANCED INDEX EQUITY ACTIVE UCITS ETF EUR H (ACC) | RVI JAPÓN | 55,297700 | 24/09/2026 | 21,29% | 91,00% | **** |
| AMUNDI MSCI JAPAN ESG BROAD TRANSITION INDEX UCITS ETF DIS | RVI JAPÓN | 67,774778 | 23/09/2026 | 21,28% | 46,96% | ** |
| COBAS GRANDES COMPAÑIAS, FI C | RVI GLOBAL VALOR | 189,182514 | 24/09/2026 | 21,28% | 93,43% | ***** |
| INVESCO JAPANESE EQUITY ADVANTAGE A CAP EUR (HEDGED) | RVI JAPÓN | 36,760000 | 24/09/2026 | 21,28% | 65,88% | *** |
| UBS (LUX) EQUITY SICAV - GLOBAL INCOME (USD) P-MDIST | RVI GLOBAL | 107,143486 | 24/09/2026 | 21,28% | 22,81% | ** |
